z-logo
Premium
An evaluation of the suitability of intravenous midazolam as an in vivo marker for hepatic cytochrome P4503A activity
Author(s) -
Rogers Janyce F.,
Rocci Mario L.,
Haughey David B.,
Bertino Joseph S.
Publication year - 2003
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1067/mcp.2003.23
Subject(s) - midazolam , in vivo , pharmacology , medicine , clinical pharmacology , biology , microbiology and biotechnology , sedation
Clinical Pharmacology & Therapeutics (2003) 73 , 153–158; doi: 10.1067/mcp.2003.23

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom